C
CSPC Pharmaceutical Group Ltd
HKEX:1093
CSPC Pharmaceutical Group Ltd
HKEX:1093
Price:
9.74
HKD
0.52%
Market Closed
Market Cap:
HK$112.2B
Relative Value
The Relative Value of one CSPC Pharmaceutical Group Ltd stock under the Base Case scenario is 5.54 HKD. Compared to the current market price of 9.74 HKD, CSPC Pharmaceutical Group Ltd is Overvalued by 43%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
5.54
HKD
Overvaluation 43%
C
Multiples Across Competitors
Competitors Multiples
CSPC Pharmaceutical Group Ltd Competitors
CSPC Pharmaceutical Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
111.8B HKD | 3.8 | 24.4 | 17.2 | 17.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
964.4B USD | 16.2 | 52.4 | 35.2 | 37.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.6B USD | 6.1 | 21.4 | 14.9 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
284.4B CHF | 4.6 | 30.2 | 12.8 | 14.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.3B GBP | 5.2 | 31.9 | 15.2 | 22.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
227.3B CHF | 5.2 | 20.3 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4 | 12.3 | 8.6 | 10 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.1B USD | 2.4 | 19.4 | 7.3 | 9.7 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.9B USD | 2.5 | 20 | 7.1 | 9.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
